Atara Biotherapeutics, Inc.
ATRA
$9.81
$1.0311.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.41M | -4.30M | 2.39M | 38.01M | -12.69M |
| Total Depreciation and Amortization | 1.05M | -964.00K | 236.00K | 1.80M | 1.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.37M | 3.36M | 2.83M | 14.17M | 9.53M |
| Change in Net Operating Assets | -1.97M | -7.88M | -12.77M | -82.11M | -22.41M |
| Cash from Operations | -5.70M | -9.79M | -7.32M | -28.14M | -24.47M |
| Capital Expenditure | -- | -- | -- | -- | -90.00K |
| Sale of Property, Plant, and Equipment | 555.00K | 44.00K | 349.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.89M | -2.47M | -5.42M | 17.20M | 3.47M |
| Cash from Investing | 8.44M | -2.42M | -5.07M | 17.20M | 3.38M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -250.00K | -235.00K |
| Issuance of Common Stock | 14.84M | 1.51M | 1.00K | -- | 50.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.84M | -461.00K | 15.30M | -- | -50.81M |
| Cash from Financing | -3.00K | 1.05M | 15.30M | -250.00K | -328.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.74M | -11.16M | 2.92M | -11.19M | -21.42M |